Cargando…
Exosomal lncRNAs from mesenchymal stem cells as the novel modulators to cardiovascular disease
AIM: Mesenchymal stem cells (MSCs) have been identified as potential therapeutic candidates for cardiovascular disease (CVD). However, the molecular mechanism underlying their therapeutic effects is unknown. FINDINGS: Recently, Chen et al. showed that an exosomal lncRNA derived from MSCs protected a...
Autor principal: | Huang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376709/ https://www.ncbi.nlm.nih.gov/pubmed/32703265 http://dx.doi.org/10.1186/s13287-020-01812-6 |
Ejemplares similares
-
New Developments in Exosomal lncRNAs in Cardiovascular Diseases
por: Yuan, Zhu, et al.
Publicado: (2021) -
Advances in lncRNAs from stem cell-derived exosome for the treatment of cardiovascular diseases
por: Ma, Jiahui, et al.
Publicado: (2022) -
Diagnostic Potential of lncRNAs in Cancer
por: Li, Chi Han, et al.
Publicado: (2016) -
Inflammation attenuating lncRNAs in diabetic cardiomyopathy
por: Mohsin, Sadia, et al.
Publicado: (2023) -
The roles of exosomal miRNAs and lncRNAs in lung diseases
por: Li, Yang, et al.
Publicado: (2019)